Cargando…
Autologous Mesenchymal Stem Cells for Treatment of Chronic Active Antibody-Mediated Kidney Graft Rejection: Report of the Phase I/II Clinical Trial Case Series
Mesenchymal stem cell (MSCs) therapy has already been studied in kidney transplant recipients (KTRs), and the available data showed that it is safe and well tolerated. The aim of this study was to evaluate the safety and efficacy of autologous MSCs in combination with standard therapy in KTRs with b...
Autores principales: | Večerić-Haler, Željka, Sever, Matjaž, Kojc, Nika, Halloran, Philip F., Boštjančič, Emanuela, Mlinšek, Gregor, Oblak, Manca, Poženel, Primož, Švajger, Urban, Hartman, Katrina, Kneževič, Miomir, Barlič, Ariana, Girandon, Lenart, Aleš Rigler, Andreja, Zver, Samo, Buturović Ponikvar, Jadranka, Arnol, Miha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722440/ https://www.ncbi.nlm.nih.gov/pubmed/36484064 http://dx.doi.org/10.3389/ti.2022.10772 |
Ejemplares similares
-
Case Report: Capillary Leak Syndrome With Kidney Transplant Failure Following Autologous Mesenchymal Stem Cell Therapy
por: Večerić-Haler, Željka, et al.
Publicado: (2021) -
Spot Urine Protein Excretion in the First Year Following Kidney Transplantation Associates With Allograft Rejection Phenotype at 1-Year Surveillance Biopsies: An Observational National-Cohort Study
por: Oblak, Manca, et al.
Publicado: (2021) -
Exploring the role of the complement system, endothelial injury, and
microRNAs in thrombotic microangiopathy after kidney
transplantation
por: Aleš Rigler, Andreja, et al.
Publicado: (2020) -
The Role of Immune-Related miRNAs in the Pathology of Kidney Transplantation
por: Boštjančič, Emanuela, et al.
Publicado: (2021) -
Management of Anticoagulant-Related Nephropathy: A Single Center Experience
por: Belčič Mikič, Tanja, et al.
Publicado: (2021)